Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Assoc. Prof. Dr. Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Associate Professor | Dima Jimma university | Ethiopia

Assoc. Prof. Dr. Feyera Gemeda Dima is a distinguished researcher and academic with extensive experience in Infectious Diseases, Medical Mycology, and Medicine. He has demonstrated excellence in teaching, research, and mentorship at both national and international levels, fostering the development of students and early-career researchers. His work emphasizes innovation in scientific research, editorial contributions, and leadership in grant assessment and curriculum development. He has contributed significantly to global collaborations and serves as a Chief Scientist and Global Assessor, reflecting his commitment to advancing scientific knowledge. His research focuses on improving understanding and management of infectious diseases, with the potential to influence public health strategies. Prof. Gemeda’s dedication to integrating innovative approaches and interdisciplinary perspectives underscores his capacity for impactful contributions in the field.

Profile:  Google Scholar

Featured Publications

1. T. Gizaw and F. G. Dima, “Assessment of problems and constraints associated with artificial insemination service in the two selected districts of Arsi zone,” Journal of Harmonized Research in Medical and Health Sciences, vol. 3, no. 1, pp. 14–37, 2016.

2. A. Edao, F. G. Dima, and F. B. Deressa, “Prevalence of bovine cysticercosis and status of human taeniasis in and around Asella town, Tiyoworeda, south east Ethiopia,” Glob J Med Res, vol. 16, pp. 18–26, 2016.

3. F. Gemeda, “Prevalence of bovine Trypanosomosis in and around Nekemte areas, east Wollega zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 05, p. 1, 2015.

4. D. T. Legesse and F. Gemeda, “Comparison of two parasitological tests and post mortem examination to detect prevalence of bovine fasciolosis at Ambo Town Municipal Abattoir, West Shewa Zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 8, pp. 1–5, 2015.

5. F. G. Dima and T. Fikedu, “Review on infectious bovine keratoconjunctivitis,” J Bacteriol Infect Dis, vol. 4, no. 4, pp. 1–6, 2021.

Dr. Gemeda’s work advances the understanding and control of infectious diseases, providing evidence-driven insights that strengthen public health systems and guide global disease management strategies.

Na Eun Lee | Extracellular Vesicles | Best Researcher Award

Ms. Na Eun Lee | Extracellular Vesicles | Best Researcher Award

Senior Research Scientist | Sungkyunkwan University | South Korea

Ms. Na Eun Lee, Ph.D. Candidate at the Department of Health Sciences and Technology (SAIHST), Sungkyunkwan University, is an accomplished researcher specializing in regenerative medicine, stem cell biology, and translational health sciences. She holds a Master’s degree in Health Sciences and Technology from Sungkyunkwan University and a Bachelor’s degree in Applied Biochemistry from Konkuk University. Currently pursuing her doctoral studies, she integrates molecular and cellular approaches to advance extracellular vesicle-based therapeutics and skin rejuvenation technologies. Throughout her professional career, Ms. Lee has held senior scientific and leadership positions at prominent biomedical companies and research institutions, where she directed projects in cell therapy development, angiogenesis research, and clinical translation. Her scholarly contributions include publications in high-impact journals such as Cytotherapy, Biochemical and Biophysical Research Communications, and the International Journal of Molecular Sciences, highlighting innovations in mesenchymal stromal cell biology and nano-encapsulation delivery systems. Renowned for her expertise in extracellular vesicle analysis, molecular diagnostics, and regenerative research, Ms. Lee’s work bridges fundamental science and clinical application. She has been recognized for her research excellence and leadership in biomedical innovation, contributing actively to the advancement of stem cell-based therapeutic strategies and representing a distinguished example of scientific dedication and translational impact in the field of health sciences and technology.

Profiles: ORCID

Featured Publications

1 S. J. Yang, J. K. Son, S. J. Hong, N. E. Lee, D. Y. Shin, S. H. Park, S. B. An, Y. C. Sung, J. B. Park, and H. M. Yang, et al., “Ectopic vascularized bone formation by human umbilical cord-derived mesenchymal stromal cells expressing bone morphogenetic factor-2 and endothelial cells,” Biochemical and Biophysical Research Communications.

2 N. E. Lee, S. J. Kim, S. J. Yang, S. Y. Joo, H. Park, K. W. Lee, H. M. Yang, and J. B. Park, “Comparative characterization of mesenchymal stromal cells from multiple abdominal adipose tissues and enrichment of angiogenic ability via CD146 molecule,” Cytotherapy.

3 H. M. Yang, H. J. Choi, D. P. Hong, S. Y. Joo, N. E. Lee, J. Y. Song, Y. L. Choi, J. Lee, D. Choi, B. Kim, et al., “The analysis of mutations and exon deletions at TSC2 gene in angiomyolipomas associated with tuberous sclerosis complex,” Experimental and Molecular Pathology.

Aneta Guzek | Bloodstream Infections | Best Researcher Award

Dr. Aneta Guzek | Bloodstream Infections | Best Researcher Award

Head of Microbial Laboratory | National Research Institute | Poland

Dr. Aneta Guzek is the Head of the Microbiology Laboratory at the Military Institute of Medicine – National Research Institute in Warsaw, Poland, specializing in medical microbiology and laboratory diagnostics. She holds a PhD in medicine with a specialization in medical microbiology from the Military Institute of Medicine, complemented by postgraduate qualifications in medical microbiology from the Medical University of Lublin and innovation management in the health care sector from Kozminski University. Additionally, she earned an MSc in biology with a focus on microbiology from the University of Warsaw and is a certified laboratory diagnostician. Dr. Guzek leads a multidisciplinary team overseeing comprehensive microbiological diagnostics, implementation of advanced diagnostic methods, and the development of institutional policies on infection control and antibiotic stewardship. Her research contributions include studies on antimicrobial resistance, hospital infection control, and the advancement of microbiological procedures, with numerous publications and citations in recognized scientific sources. She collaborates with national and reference laboratories, contributing to public health and medical innovation. Her exemplary service has been recognized with prestigious honors, including the first place in the Hippocrates Medical Poll for Laboratory Diagnostician of the Year and the Badge of Honour from the Military Medical Institute for her efforts during the COVID-19 pandemic. Dr. Guzek also holds certification in Good Clinical Practice (ICH E6 R2), underscoring her commitment to excellence in research and clinical integrity.

Profiles: Scopus | ORCID

Featured Publications

1. Guzek, A., et al. (2025). Microbiological comparison of maxillary sinus rinses in non-odontogenic and odontogenic sinusitis of primarily endodontic origin. Journal of Clinical Medicine.

2. Guzek, A., et al. (2024). Outcomes of 23 patients diagnosed with New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae infection treated with ceftazidime/avibactam and aztreonam at a single center in Poland. Journal of Clinical Medicine.

3. Guzek, A., et al. (2024). Dissemination of extensively drug-resistant NDM-producing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023. Eurosurveillance.

Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Dr. Mantosh Kumar Satapathy | Pharmacology | Best Researcher Award

Mantosh Kumar Satapathy  | Taipei Medical University | Taiwan

Dr. Mantosh Kumar Satapathy, Ph.D., is a distinguished biomedical scientist, biotechnologist, pharmacologist, and tissue engineer based at Taipei Medical University, Taiwan, with extensive international experience in pharmacology, biomedical engineering, and nanobiotechnology. He earned his Ph.D. in Biomedical Materials and Tissue Engineering from Taipei Medical University, following an M.Tech. in Industrial Biotechnology and a Bachelor of Pharmacy, establishing a strong foundation in translational medical research. Dr. Satapathy has held postdoctoral and research fellow positions at leading institutions, leading projects on advanced nanodrug delivery systems, stem cell therapeutics, tissue engineering, and nanoformulation design, while supervising molecular biology laboratories and mentoring junior researchers. His research contributions include the development of stimuli-responsive nanocomposite hydrogels for orthopedic and skin tissue regeneration, engineering of nanocurcumin-based formulations for targeted therapies, and investigations into gene regulation and drug repurposing in cancer and skin pathologies. He has published extensively in high-impact peer-reviewed journals, contributed to international book chapters, co-invented a U.S. patent, and presented his work at global scientific conferences. Dr. Satapathy’s work has been recognized with multiple Outstanding Postdoctoral Researcher awards, and he actively serves as a peer reviewer, reflecting his leadership in the scientific community. He is a life member of professional organizations, has completed specialized research training in molecular diagnostics and biotechnology, and continues to advance interdisciplinary research that bridges fundamental science and clinical application, demonstrating exceptional impact in biomedical innovation.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Banerjee, P., Satapathy, M., Mukhopahayay, A., & Das, P. (2014). Leaf extract mediated green synthesis of silver nanoparticles from widely available Indian plants: Synthesis, characterization, antimicrobial property and toxicity analysis. Bioresources and Bioprocessing, 1(1), 3.

2. Satapathy, M. K., Yen, T. L., Jan, J. S., Tang, R. D., Wang, J. Y., Taliyan, R., & Yang, C. H. (2021). Solid lipid nanoparticles (SLNs): An advanced drug delivery system targeting brain through BBB. Pharmaceutics, 13(8), 1183.

3. Satapathy, M. K., & Das, P. (2014). Optimization of crystal violet dye removal using novel soil-silver nanocomposite as nanoadsorbent using response surface methodology. Journal of Environmental Chemical Engineering, 2(1), 708–714.

4. Satapathy, M. K., Banerjee, P., & Das, P. (2015). Plant-mediated synthesis of silver-nanocomposite as novel effective azo dye adsorbent. Applied Nanoscience, 5(1), 1–9.

5. Satapathy, M. K., Nyambat, B., Chiang, C. W., Chen, C. H., Wong, P. C., Ho, P. H., … (2018). A gelatin hydrogel-containing nano-organic PEI–Ppy with a photothermal responsive effect for tissue engineering applications. Molecules, 23(6), 1256.

Judita Kinkorova | Biobanking | Best Researcher Award 

Assoc. Prof. Dr. Judita Kinkorova | Biobanking | Best Researcher Award 

Senior Scientist | University Hospital in Pilsen | Czech Republic

Assoc. Prof. Dr. Judita Kinkorová is a leading researcher in biobanking, personalized medicine, and preventive healthcare, recognized for her significant contributions to international research collaboration. She has successfully coordinated major European research initiatives, including FP7 and Horizon 2020 projects, and has played a pivotal role in developing hospital-integrated biobanks that strengthen biomedical research infrastructure. Her active participation in scientific societies and editorial boards reflects her influence and thought leadership in advancing precision health. Dr. Kinkorová’s work integrates scientific rigor with strategic collaboration, mentorship, and policy engagement, demonstrating strong potential for further innovation in genomic and biomarker research, sustainable biobanking, and cross-border scientific partnerships. Her research output is substantial, comprising 47 Scopus-indexed publications, cited 852 times by 744 documents, with an h-index of 12, highlighting the measurable impact and quality of her contributions to the field.

Profile: Scopus | ORCID

Featured Publications

1. J. Kinkorová and O. Topolčan, “Biobanks in the era of big data: objectives, challenges, perspectives, and innovations for predictive, preventive, and personalised medicine,” EPMA Journal, 2020.

2. J. Kinkorová, O. Topolčan, and R. Kučera, “Informed Consent in the Newly Established Biobank,” International Journal of Environmental Research and Public Health, 2019.

3. J. Kinkorová and O. Topolčan, “Biobanks in Horizon 2020: sustainability and attractive perspectives,” EPMA Journal, 2018.

4. “The 44th Congress of the International Society of Oncology and Biomarkers: Rio de Janeiro, Brazil, 7-10 September 2017,” Future Medicine, 2018.

5. J. Kinkorová and O. Topolčan, “Biobanks – European infrastructur | Biobanky – Evropská infrastruktura,” Casopis Lekaru Ceskych, 2016.

Sharadamma Narayanaswamy | Molecular Biology | Best Researcher Award

Dr. Sharadamma Narayanaswamy | Molecular Biology | Best Researcher Award

Associate Professor at REVA University | India

Dr. Sharadamma Narayanaswamy is an accomplished researcher and academician with extensive expertise in biochemistry and molecular biology. Her career spans significant contributions in enzyme studies, microbial research, and the biochemical characterization of nucleoid-associated proteins in Mycobacterium tuberculosis. With strong experience in advanced techniques such as protein purification, cloning, expression, site-directed mutagenesis, and immunological assays, she has established herself as a skilled experimentalist and mentor. She has guided numerous postgraduate students, successfully completed funded projects, and actively engaged in developing innovative research initiatives with societal and scientific relevance. Her teaching experience across leading institutions has enriched her ability to integrate research with pedagogy, inspiring students to pursue scientific inquiry. Recognized with awards such as Best Researcher, she has consistently demonstrated excellence and dedication to her field. Her commitment to research, teaching, and mentorship highlights her as a valuable contributor to advancing knowledge in biochemistry.

Professional Profile 

Scopus Profile 

Education

Dr. Sharadamma Narayanaswamy has pursued a strong academic foundation in the field of biochemistry and allied sciences. She earned her Ph.D. in Biochemistry from Bangalore University, where she worked extensively on enzyme studies and microbial research. She also holds a Post-Doctoral Research Associate fellowship from the Indian Institute of Science, Bengaluru, where she gained advanced training in molecular biology and protein chemistry. Her academic qualifications further include an M.Sc. in Biochemistry, B.Ed., and successful completion of SLET/NET, which reflect her comprehensive preparation for both teaching and research. Through her academic journey, she developed a strong expertise in enzymology, protein chemistry, and microbial biochemistry. Her advanced education and specialized training in cutting-edge techniques have enabled her to establish a career combining research, teaching, and mentoring. These academic achievements laid the groundwork for her impactful contributions in higher education and scientific research.

Experience

Dr. Sharadamma Narayanaswamy has over two decades of teaching and research experience across reputed institutions. She has served as a guest faculty, assistant professor, and now as an associate professor in the Department of Biochemistry at REVA University. In these roles, she has handled diverse subjects including biomolecules, clinical biochemistry, molecular biology, recombinant DNA technology, and endocrinology, while mentoring postgraduate students in research projects. Her career has also involved guiding seminars, practical training, and organizing academic activities, which demonstrate her ability to integrate classroom teaching with applied scientific skills. In addition to her teaching, she has actively contributed as a research mentor by supervising funded projects and student research initiatives. Her rich professional experience reflects a balance of pedagogy, research, and leadership, enabling her to influence both academic learning and scientific advancement. She continues to be a committed educator and researcher, shaping future scientists.

Research Focus

Dr. Sharadamma Narayanaswamy’s research interests lie at the intersection of biochemistry, enzymology, and molecular biology, with a focus on protein characterization and microbial biochemistry. Her early research included purification and kinetic studies of enzymes such as β-amylase, followed by doctoral work on tannin-degrading enzymes from soil microorganisms. As a postdoctoral researcher, she advanced to studying nucleoid-associated proteins from Mycobacterium tuberculosis, exploring their roles in DNA interactions and cellular regulation. She has developed expertise in molecular cloning, protein purification, EMSA, mutagenesis, and advanced biochemical assays. More recently, her work has expanded into applied research addressing challenges such as pest management using biochemical approaches. She has successfully completed institutional and externally funded projects, emphasizing both fundamental and applied dimensions of science. Her research reflects a deep commitment to solving scientific problems with societal impact, while contributing to the broader understanding of biochemical mechanisms and microbial systems.

Award and Honor

Dr. Sharadamma Narayanaswamy has been recognized for her significant contributions to research and education through several awards and honors. She received the Research Associate fellowship from the Department of Biotechnology, Government of India, which allowed her to undertake advanced postdoctoral work at the Indian Institute of Science. She has been honored with the Best Student Research Project Award by InSc and multiple recognitions for guiding innovative postgraduate research, including the Best M.Sc. Student Project under government-funded programs. Notably, she was awarded the Best Researcher Award at REVA University, acknowledging her sustained excellence in research and mentorship. These achievements reflect her ability to contribute to both academic and applied research while nurturing young scientists. Her recognition at institutional, state, and national levels highlights her reputation as a dedicated researcher and teacher. The awards stand as a testament to her hard work, innovation, and lasting impact in the field of biochemistry.

Publication Top Notes

  • Title: Biochemical profiling of plant latex Euphorbia hirta and Croton bonplandianum: Unveiling the nuclease and protease activity

  • Authors: Sharadamma Narayanaswamy, Nagesh Babu Rangappa, B M Chaithanya Rai, Likhitha J, Debasree Basu Mukherjee

  • Year: 2025

Conclusion

The publication “Biochemical profiling of plant latex Euphorbia hirta and Croton bonplandianum: Unveiling the nuclease and protease activity” highlights the potential of plant latex as a natural source of bioactive enzymes with significant biochemical applications. By uncovering nuclease and protease activities, this research contributes to the growing body of evidence supporting the therapeutic and industrial relevance of plant-derived biomolecules. Though still in the early stages of citation and recognition, the study demonstrates innovation and provides a foundation for future exploration into medicinal plant biochemistry. It reflects the authors’ commitment to advancing knowledge in enzyme research and opens new avenues for biotechnological and pharmaceutical applications.

Muhammad Bakhsh | Vaccine | Best Researcher Award

Mr. Muhammad Bakhsh | Vaccine | Best Researcher Award

Post Graduate Student at Jeonbuk National University (JBNU), South Korea

Muhammad Bakhsh is a passionate veterinary researcher from Pakistan, deeply engaged in the fields of microbiology, virology, and public health. With a Doctor of Veterinary Medicine (DVM) from the University of Veterinary and Animal Sciences (UVAS), Lahore, he has cultivated both academic depth and practical experience in veterinary sciences. Currently serving as a Master Trainer at UVAS’s Para Veterinary Institute, he is actively involved in teaching, clinical supervision, and laboratory diagnostics. He also serves on the editorial boards of several scientific publications and is a reviewer for an international veterinary journal. Muhammad has contributed to multiple peer-reviewed publications, book chapters, and conference proceedings. Beyond academia, he is a strong advocate of the One Health concept, bridging animal and human health research. His dedication, collaborative mindset, and early achievements mark him as a rising contributor to Pakistan’s veterinary and public health sectors.

Professional Profile 

Google Scholar

Education 

Muhammad Bakhsh earned his Doctor of Veterinary Medicine (DVM) from the University of Veterinary and Animal Sciences (UVAS), Lahore, where he developed strong foundations in veterinary microbiology, immunology, epidemiology, and animal breeding. His academic training included rigorous coursework and clinical rotations in disease diagnostics, treatment, and prevention. Throughout his studies, Muhammad showed keen interest in zoonotic disease control, food safety, and animal welfare, which shaped his later research focus. In addition to his formal veterinary degree, he has completed multiple international certifications and online courses on topics such as antimicrobial resistance, sustainable food production, animal welfare, and biosafety from institutions like the University of Illinois, DTU Denmark, and the University of Edinburgh. These supplementary trainings have enhanced his global perspective on public and animal health issues. His education reflects a balanced blend of technical veterinary knowledge, public health awareness, and research capability across multiple disciplines.

Experience

Muhammad Bakhsh has built a versatile portfolio of academic, clinical, and research experiences. Currently, he serves as a Master Trainer at the Para Veterinary Institute (PVI) under the University of Veterinary and Animal Sciences (UVAS), where he delivers lectures for diploma courses, supervises veterinary hospital activities, and engages in laboratory diagnostics. He also worked as a Research Volunteer, contributing to seroprevalence studies on zoonotic infections like Toxoplasma gondii in goats. Earlier, he served as the Scientific Research Head of a veterinary academic club, helping peers with research writing and thesis development. His editorial and peer review work with The Veterinary News and Views and Acta Scientific Veterinary Sciences highlights his academic credibility. He has actively participated in national and international conferences, presented abstracts, and contributed to public health education through extension articles. His diverse experience reflects strong teaching, diagnostic, and scientific communication capabilities.

Awards and Honors

Muhammad Bakhsh has received multiple recognitions throughout his academic and professional journey. Notably, he secured first position in the Chief Minister’s Essay Writing Competition at the divisional level, awarded by the Government of Punjab, reflecting his early promise in scientific communication. His contributions to student leadership in public health were acknowledged in a national initiative by the U.S. Mission Pakistan and Pak-US Alumni Network. His editorial and review positions with scientific journals also signify recognition by the broader academic community. In addition, he has participated in high-profile international workshops and virtual veterinary conferences, further solidifying his academic footprint. These honors reflect his multifaceted abilities—not only as a researcher but also as an effective communicator, mentor, and advocate for One Health. Through continuous professional development and scholarly contribution, Muhammad Bakhsh has earned respect within both veterinary and public health networks across Pakistan and South Asia.

Research Focus on Vaccine

Muhammad Bakhsh’s research focuses on zoonotic diseases, veterinary microbiology, antimicrobial resistance, and public health. His work includes seroprevalence and molecular studies on pathogens like Toxoplasma gondii, Trypanosoma evansi, and Campylobacter, with emphasis on detection, epidemiology, and therapeutic interventions. He has contributed to studies exploring the role of fish in global food security, the efficacy of zinc nanoparticles in wound healing, and alternatives to antibiotics in poultry health. His approach integrates lab-based diagnostics with field-based data collection, reflecting a holistic understanding of disease control. Muhammad is particularly aligned with the One Health approach, advocating for the interconnected health of animals, humans, and the environment. He is also involved in research communications, authoring extension articles that translate complex scientific ideas into public awareness. His vision centers on using research to improve food safety, reduce disease burdens, and contribute to sustainable livestock health management in Pakistan and beyond.

Publications Top Notes

  • Title: An overview of bovine cystic ovarian disease
    Authors: A. Channo, A. Kaka, Q. Kalwar, I. Jamali, G. Jelani, M. Bakhsh, G.N. Dahri, et al.
    Year: 2022
    Citations: 15

  • Title: Effect of soybean milk and tris egg yolk based extender on semen quality parameters of Tharparkar bull
    Authors: A.S. Memon, A. Kaka, A. Channo, M. Bakhsh, Q. Kalwar, A. Sethar
    Year: 2022
    Citations: 7

  • Title: Molecular detection and therapeutic study of Trypanosoma brucei evansi from naturally infected horses in Punjab, Pakistan
    Authors: J. Zahoor, M. Kashif, A. Nasir, M. Bakhsh, M.F. Qamar, A. Sikandar, A. Rehman
    Year: 2022
    Citations: 6

  • Title: The Role of Fish in Global Food and Nutrition Security: Current Aspects and Future Prospect
    Authors: M. Bakhsh, M.H. Ghazali, M.K. Yar, A. Channo, M. Kashif, M. Ijaz, et al.
    Year: 2023
    Citations: 5

  • Title: Comparison of the effect of zinc oxide nanoparticles and extract of Acorus calamus applied topically on surgical wounds inflicted on the skin of rabbits
    Authors: A. Abbas, S.A. Muhammad, A. Ashar, S.A. Mehfooz, A. Rauf, M. Bakhsh, et al.
    Year: 2023
    Citations: 5

  • Title: Camel meat production, consumption and nutritive value: Present status and future prospects
    Authors: M.H. Ghazali, M. Bakhsh, U. Zainab, A. Faraz, M.U. Munir, A. Channo, et al.
    Year: 2023
    Citations: 5

  • Title: Sero-epidemiology, therapeutic study and the risk factors associated with Trypanosomiasis (Surra) in camels in District Jhang, Punjab, Pakistan
    Authors: J. Zahoor, M. Kashif, A. Nasir, M. Bakhsh, A.U. Rehman, A. Sikandar, et al.
    Year: 2023
    Citations: 3

  • Title: Post Thawed Quality of Tharparkar Bull Semen Extended in Bioxcell™ and Tris-Based Egg Yolk Extenders Supplemented with Vitamin E (α-Tocopherol)
    Authors: A. Channo, A. Kaka, A.A. Memon, M. Chand, M.B. Malhi, Q. Kalwar, S.A. Tunio, M. Bakhsh, et al.
    Year: 2023
    Citations: 3

Conclusion

Muhammad Bakhsh exemplifies the qualities of an impactful early-career researcher in veterinary and public health sciences. His contributions span peer-reviewed publications, public health outreach, laboratory diagnostics, and academic training. With a growing citation record and experience across zoonotic disease surveillance, antimicrobial resistance, and animal welfare, he demonstrates a balanced blend of scientific inquiry and real-world application. His active roles in editorial boards, teaching, and international workshops reflect both academic recognition and leadership potential. While still at the early stages of his career, his research direction aligns well with global priorities like One Health, food safety, and sustainable livestock practices. Continued specialization, international collaboration, and lead authorship will further elevate his research standing. Overall, Muhammad Bakhsh is a promising and dedicated researcher whose work is already contributing meaningfully to science and society—and he is well on track to becoming a leader in the veterinary research community.

Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Dr. Yoana Dyankova | Medicine and Dentistry | Best Researcher Award

Doctor at Medical University, Varna, Bulgaria

Dr. Yoana Dyankova Dyankova is a dedicated pediatrician and clinical researcher specializing in pediatric gastroenterology, hepatology, and nutrition. She holds a PhD in Pediatrics from the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, where she also serves in the Pediatric Intensive Care Unit at St. Marina University Hospital. Her research focuses primarily on celiac disease in children, particularly its impact on bone health, as demonstrated in her dissertation and multiple peer-reviewed publications, including a recent article in Nutrients (2025). Dr. Dyankova is an active member of national pediatric and gastroenterology associations and contributes to both clinical care and academic development. Fluent in English and German, she engages with the international scientific community and remains committed to translating research into improved patient outcomes. With her growing publication record, clinical integration, and academic rigor, she stands out as a promising young researcher in the field of pediatric medicine.

Professional Profile 

Google Scholar
ORCID Profile 

Education

Dr. Yoana Dyankova Dyankova began her academic journey at the Vasil Drumev High School of Natural Sciences and Mathematics in Veliko Tarnovo, graduating in 2010. She pursued her medical degree at the Medical University “Prof. Dr. Paraskev Stoyanov” in Varna, Bulgaria, completing it in 2016. From 2017 to 2022, she specialized in pediatrics, gaining comprehensive clinical training and board certification in the field. In 2018, she enrolled in a PhD program in Pediatrics at the same university, where she focused her research on celiac disease and its effects on pediatric bone health. She successfully defended her dissertation in 2023. Dr. Dyankova has since continued to develop professionally by pursuing further specialization in pediatric gastroenterology starting in July 2025. Her academic path demonstrates strong commitment, discipline, and a focused interest in improving pediatric healthcare through both clinical practice and rigorous scientific research.

Professional Experience

Dr. Dyankova has cultivated a balanced career combining clinical excellence and academic growth. Since January 2022, she has served as a pediatrician at the Pediatric Intensive Care Unit (PICU) of the First Children’s Clinic, St. Marina University Hospital in Varna. Her role in the PICU places her at the frontline of managing critically ill children, often requiring advanced decision-making and teamwork in high-pressure situations. Prior to this, she completed a five-year pediatric residency, gaining hands-on experience in general pediatrics. Her transition into the subspecialty of pediatric gastroenterology as of July 2025 marks a strategic shift aligned with her research interests. Parallel to her clinical duties, Dr. Dyankova was engaged in doctoral studies for five years, conducting original research and contributing to academic publications. Her dual role as both a clinician and researcher enhances her ability to apply scientific findings directly to patient care, making her a valuable asset in modern pediatric medicine.

Research Interest

Dr. Dyankova’s primary research interests lie at the intersection of pediatric gastroenterology, hepatology, and nutrition, with a concentrated focus on celiac disease (CD). Her doctoral thesis explored bone health in children with CD, addressing the metabolic and developmental complications arising from malabsorption and chronic inflammation. Beyond celiac disease, she has expressed research interest in related gastrointestinal disorders such as inflammatory bowel disease (IBD), as well as broader issues within pediatric intensive care. Her work is characterized by clinical relevance and translational value, aiming to bridge the gap between scientific research and bedside care. Publications in both national and international journals reflect her dedication to improving diagnostic and treatment protocols in children with chronic gastrointestinal conditions. Dr. Dyankova continues to build her research portfolio by participating in collaborative studies, focusing on early diagnosis, nutritional interventions, and long-term management outcomes in affected pediatric populations, ensuring a direct impact on clinical practice.

Award and Honor

While specific named awards are not listed in the biography, Dr. Yoana Dyankova Dyankova has received notable academic and professional recognition through her successful completion of a PhD and multiple scientific publications. Her research has been published in reputable journals such as Nutrients, indicating peer validation and relevance of her work. She is an active member of the National Pediatric Association and the community of Pediatric Gastroenterologists in Bulgaria, reflecting her standing in the professional community. These memberships signify not only recognition by peers but also her continued contribution to scientific discussions and advancements in pediatric healthcare. Her role in high-stakes clinical environments like the Pediatric Intensive Care Unit further demonstrates trust in her medical competence and decision-making. With growing academic output and clear specialization in a crucial field, Dr. Dyankova is well-positioned to earn future distinctions and leadership roles in pediatric research and clinical practice at both national and international levels.

Conclusion

Dr. Yoana Dyankova Dyankova exemplifies the qualities of a dedicated clinician-scientist, balancing hands-on pediatric care with high-impact academic research. With a solid foundation in pediatrics and a focused interest in gastroenterology and nutrition, she has steadily advanced her career through both clinical excellence and scholarly contribution. Her doctoral work on bone health in children with celiac disease highlights her ability to address complex, real-world health challenges through evidence-based research. Now working in a pediatric intensive care setting and continuing her subspecialty training, Dr. Dyankova is expanding her expertise and influence in critical areas of child health. Her publications, professional affiliations, and academic achievements underscore a deep commitment to the advancement of pediatric medicine. While still early in her career, her trajectory suggests strong potential for leadership in research and healthcare. She is a promising candidate for recognition such as the Best Researcher Award and is well-poised for continued professional impact.

Publications Top Notes

  1. Title: Presentation of Childhood Newly-Diagnosed Diabetes During the COVID-19 Pandemic – Is There a Change?

    • Authors: Y. Bazdarska, V. Iotova, T. Karamfilova, Y. Dyankova, T. Stefanova, …

    • Journal: Diabetes Technology & Therapeutics, Vol. 23, A202

    • Year: 2021

  1. Title: Delayed Bone Age and Osteoprotegerin Levels in Pediatric Celiac Disease: A Three-Year Case–Control Study

    • Authors: R. Pancheva, Y. Dyankova, N. Rasheva, K. Koleva, V. Iotova, M. Dzhogova, M. Fiore, M. Georgieva

    • Journal: Nutrients, Vol. 17 (14), Article 2295

    • Year: 2025

  1. Title: Macrophage Activation Syndrome After COVID-19 Infection in a Patient with Systemic Juvenile Idiopathic Arthritis

    • Authors: M. Boyadzhiev, B. Varbanova, M. Belcheva, P. Shivachev, D. Krumova, Y. Dyankova, …

    • Journal: Scripta Scientifica Medica, Vol. 55(1), pp. 27–31

    • Year: 2023

  1. Title: Bone Health in Children with Celiac Disease (PhD Dissertation)

    • Author: Y. Dyankova

    • Database: PQDT-Global (ProQuest Dissertations)

    • Year: 2022

  1. Title: New Developments in the Diagnostics of Celiac Disease in Children

    • Authors: Y. Dyankova, M. Georgieva, N. Rasheva, K. Koleva

    • Journal: Journal of the Union of Scientists-Varna. Medicine and Ecology Series, Vol. 24(1)

    • Year: 2019

  1. Title: Bacterial Pulmonary Colonization with Pseudomonas aeruginosa in Cystic Fibrosis Patients

    • Authors: M. Nikolova, Y. Dyankova, I. Hristov, M. Georgieva

    • Journal: Izvestia Journal of the Union of Scientists-Varna. Medicine and Ecology Series

    • Year: 2019

Nai-Dong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Prof. Nai-Dong Chen | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

department leader at West Anhui University, China

Professor Chen, born in September 1972 in Jinzhai County, Anhui Province, is a distinguished scholar and a leading figure in the field of traditional Chinese medicine and natural product research. Currently, he serves as a Distinguished Professor (Dabieshan Scholar) at West Anhui University, where he also holds multiple leadership roles, including Deputy Director of the Experimental Teaching and Training Management Department, and Director of the Postdoctoral Research Workstation. He is a doctoral supervisor affiliated with Anhui University of Chinese Medicine and Anhui Agricultural University, and leads the Anhui Provincial Key Laboratory of Traditional Chinese Medicine Quality Evaluation and Enhancement. Prof. Chen is also the head of several strategic research teams and innovation platforms that focus on the modernization and industrialization of herbal medicine. A nationally recognized talent under the Anhui Provincial Special Support Plan, he has been honored as a Top Talent of Lu’an City, Outstanding Teaching Faculty of West Anhui University, and nominee for Lu’an Distinguished Talent Award. His scholarly influence is reinforced by his role as a reviewer for the National Natural Science Foundation and active participation in national academic societies, contributing to both academic and practical advancements in pharmaceutical science.

Professional Profile

Education

Professor Chen holds a PhD in Pharmaceutical Sciences, which provided the foundation for his career-long dedication to the research and development of traditional Chinese medicine. With a strong academic background rooted in pharmacy, chemistry, and biotechnology, his educational journey integrated classical medicinal knowledge with modern scientific methodology. Over the years, he has further enhanced his qualifications through postdoctoral research and continuous academic training, establishing himself as a multidisciplinary expert. His early education fostered a strong commitment to scientific excellence and innovation, particularly in areas such as medicinal chemistry, pharmacology, and natural product extraction. His academic milestones have been complemented by hands-on experience in laboratory work, clinical trials, and academic leadership. Prof. Chen’s teaching and mentorship roles at institutions such as Anhui University of Chinese Medicine and Anhui Agricultural University reflect a solid academic lineage and dedication to nurturing the next generation of researchers. His consistent academic growth, paired with strategic collaboration with scientific institutions, has enabled him to contribute meaningfully to the evolving landscape of pharmaceutical education in China. His educational achievements form the intellectual backbone of his extensive work in TCM standardization, drug development, and plant-based biomedicine.

Professional Experience

Throughout his career, Professor Chen has accumulated a wealth of professional experience spanning academia, research administration, and national-level scientific leadership. As a Professor at West Anhui University, he has played a pivotal role in curriculum development, talent cultivation, and institutional research strategy. He concurrently serves as Vice Secretary of the Party Committee and Deputy Director of the Experimental Training Management Department, while also leading the Postdoctoral Workstation and provincial laboratories in quality enhancement of traditional Chinese medicine. Prof. Chen is the Chief Investigator and Team Leader of several key innovation teams focused on medicinal plant research and pharmacological innovation. Beyond his university, he is deeply involved in provincial and national science policymaking, contributing as a Communications Reviewer for NSFC, and as a standing member of the Chinese Under-Forest Economy Society and Anhui Botanical Society. Over the years, he has led or participated in over 20 major scientific research projects, with total funding in the multimillion-yuan range. His work often bridges the gap between academia and industry, evidenced by extensive industry-academic collaboration, numerous patents, and standard-setting activities. His experience reflects a mature balance of teaching, research, and service that defines his leadership in Chinese pharmaceutical sciences.

Research Interests

Professor Chen research interests center on the quality evaluation, efficacy enhancement, and innovation of traditional Chinese medicines (TCMs). A key focus of his work is the phytochemistry, pharmacokinetics, and bioactivity of medicinal herbs, particularly Dendrobium huoshanense, a rare and valuable plant species. His investigations delve into metabolomics, network pharmacology, and structure-activity relationships, aiming to improve standardization and therapeutic potential of herbal products. He has also led efforts to decode the geographical specificity (daodi) and biological transformation mechanisms of active components in medicinal plants. His interest in synergistic fermentation, antioxidant activity, and enzyme inhibition studies has resulted in innovative methods for improving bioavailability and therapeutic outcomes of plant-based compounds. Additionally, Professor Chen integrates modern analytical technologies such as UPLC-MS/MS, NIR spectroscopy, and bioinformatics into his research toolkit, enhancing the precision and scalability of TCM research. His collaborative work with pharmaceutical companies aims to commercialize novel herbal formulations and functional health products. As TCM gains global interest, Prof. Chen’s research aligns with the trend of merging traditional knowledge with cutting-edge biomedical science, addressing critical issues in herbal medicine safety, efficacy, and modernization.

Awards and Honors

Professor Chen has been recognized with numerous prestigious awards and honors, reflecting his profound impact on pharmaceutical research and education. Among his most notable achievements are two Second Prizes for Science and Technology Progress in Anhui Province and the Special Award for Technological Advancement by the China General Chamber of Commerce. These accolades signify his contributions to both fundamental science and its practical application in the modernization of traditional Chinese medicine. He was also honored with the Anhui Provincial Teaching Achievement Award (Second Prize), highlighting his role in academic innovation and pedagogy. As a recipient of the Anhui Provincial Leading Talent under the Special Support Plan, Prof. Chen is acknowledged as a strategic scientific leader. He has been awarded Top Talent and Outstanding Scholar titles in Lu’an City, and recognized as a Teaching Master at West Anhui University. His selection as Principal Investigator for National Natural Science Foundation of China (NSFC) projects further underscores his status in China’s scientific community. With over 40 patent applications, 23 industry and local standards developed, and extensive mentorship roles, his accolades are both deep and diverse. These honors confirm his legacy as a highly influential and respected figure in biomedical and TCM research.

Conclusion

Professor 陈乃东 is a highly suitable candidate for the Best Researcher Award. His outstanding achievements in TCM quality research, natural products pharmacology, and regional development through science and innovation reflect the hallmarks of a leading researcher. His contributions are scientifically rigorous, socially relevant, and academically influential. With minor enhancements in global engagement and innovation translation, his profile could further stand out on the world stage.

Publications Top Notes

  • Author(s): Hao, Jingwen; Wang, Weiting; Chen, Naidong; Shen, Yan
    Year: 2025
    Title: Identification of 13 natural antioxidants in green calyx plum using AAPH, ABTS, and FRAP-coupled HPLC-DAD via QTOF-MS/MS
    Journal: Food Chemistry
    Citations: 0

  • Author(s): Chen, Naidong
    Year: 2025
    Title: Mechanism for the Inhibition of α-Glucosidase by Peptide Tyr-Pro-Ile-Trp (YPIW) and Its Stability
    Journal: Shipin Kexue / Food Science
    Citations: 0

  • Author(s): Zheng, Shaojun; Li, Sheng; Diao, Xiaohan; Chen, Naidong
    Year: 2025
    Title: Prunus mume Alleviates Hyperuricemic Renal Injury: Insights From Network Pharmacology and Experimental Models
    Journal: Biomedical Chromatography
    Citations: 0

  • Author(s): Hao, Kuku; Wang, Qijin; Wei, Shengxiang; Zheng, Shaojun; Zhang, Manman; Chen, Naidong (co-author)
    Year: 2025
    Title: Structural characterization and anti-inflammatory activity of a neutral polysaccharide from Dendrobium huoshanense C. Z. Tang et S. J. Cheng
    Journal: International Journal of Biological Macromolecules
    Citations: 0

  • Author(s): Hao, Jingwen; Fan, Xuanxuan; Chen, Naidong; Xiao, Jun; Zhang, Manman
    Year: 2025
    Title: A novel method for the simultaneous determination of flavonoids in Pteridium aquilinum via SPE combined with UPLC-DAD via QAMS
    Journal: Journal of Food Composition and Analysis
    Citations: 0

 

Anish Maskey | Immunology and Microbiology | Best Researcher Award

Dr. Anish Maskey | Immunology and Microbiology | Best Researcher Award

Postdoctoral Fellow at New York Medical College, United States

Dr. Anish R. Maskey is a dedicated postdoctoral fellow at the Department of Pathology, Microbiology & Immunology at New York Medical College, with a specialized focus on allergy, immunology, and infectious diseases. With an in-depth understanding of translational research, he integrates bench-to-bedside approaches, concentrating on biomarker discovery, immune response profiling, and therapeutic evaluation for allergic and inflammatory conditions. Over the past six years, he has built a strong scientific portfolio in both academic and clinical research settings, with active involvement in designing, executing, and analyzing preclinical studies using in-vitro systems, human samples, and murine models. His collaborative nature and leadership skills are evident through his mentorship of over 25 trainees, active role in multi-institutional conferences, and contribution to peer-reviewed journals. Dr. Maskey’s publication record includes multiple first-author and collaborative studies in prominent journals like Frontiers in Allergy, Cells, and The Journal of Inflammation Research. His scientific acumen is matched by his commitment to education and community-building in science. As a member of multiple professional societies and editorial boards, he continues to shape the future of immunological research while fostering international collaboration and integrative medical approaches. His work represents a blend of scientific excellence, innovation, and societal impact.

Professional Profile

Education

Dr. Anish R. Maskey holds a Ph.D. in Pathology, Microbiology, and Immunology from New York Medical College, which he earned in 2023 with a commendable CGPA of 3.75/4. His doctoral research was centered on discovering small molecule compounds—particularly from Traditional Chinese Medicine—as novel therapeutics for eosinophilic esophagitis. This body of work laid the foundation for his expertise in allergic diseases, immunomodulation, and translational medicine. Prior to his Ph.D., Dr. Maskey completed his Bachelor of Science in Medical Laboratory Technology from the Institute of Medicine in Kathmandu, Nepal, graduating in 2016 with a strong academic record of 72%. His educational journey reflects a continual evolution from clinical laboratory sciences to cutting-edge immunological research, underpinned by rigorous training in microbiology, molecular biology, and clinical diagnostics. Beyond formal education, he has also actively pursued professional development through certifications in clinical trial ethics, laboratory safety, peer reviewing, and biomedical research compliance under platforms such as CITI and Elsevier. These educational milestones not only showcase Dr. Maskey’s technical proficiency but also his commitment to lifelong learning, scientific integrity, and the ethical conduct of human and animal research. His academic background enables him to operate seamlessly at the intersection of clinical science and laboratory innovation.

Professional Experience

Dr. Maskey currently serves as a postdoctoral fellow at New York Medical College, where he works under the mentorship of Dr. Xiu-Min Li on multiple NIH-funded projects related to allergic diseases, microbiome therapy, and drug discovery. He is the Co-Investigator or Co-Principal Investigator on several high-impact translational research studies involving human clinical samples and murine models. His work explores the therapeutic efficacy of natural compounds on conditions such as eczema, food allergies, eosinophilic esophagitis, and antibiotic-resistant infections. Previously, during his Ph.D. candidacy (2018–2023), he led key investigations on chronic inflammatory diseases and mentored junior researchers while also teaching advanced immunology and microbiology courses. Dr. Maskey has authored or co-authored over 15 peer-reviewed publications and actively contributes as an editorial board member and peer reviewer for journals such as Frontiers in Allergy and The FASEB Journal. In his leadership roles, he has managed research teams, coordinated research conferences, and overseen protocol development and compliance for IRB and IACUC projects. His professional experience reflects a dynamic integration of teaching, research, mentorship, and administration, underlining his preparedness for independent academic or industry-based scientific leadership roles in immunology, microbiology, and translational medicine.

Research Interests

Dr. Anish R. Maskey’s research interests span allergy and immunology, host-pathogen interactions, microbiome-based therapy, and immune modulation using natural compounds. His primary focus lies in discovering and validating biomarkers for allergic diseases, including food allergies, eczema, eosinophilic esophagitis, and drug-resistant infections. Dr. Maskey is particularly interested in translational and integrative approaches to treating chronic inflammation by bridging clinical medicine with basic science. Through his ongoing work on immune profiling, he explores cytokine signaling, IgE-mediated hypersensitivity, mast cell activation, and epigenetic regulation of Th2 responses. He has established various murine models for food allergies, eczema, and Staphylococcus aureus infections to test the efficacy and mechanisms of plant-based therapeutics like berberine and ganoderic acid. Additionally, he investigates the skin and gut microbiomes’ roles in disease progression and recovery, utilizing both in-vivo and ex-vivo models. His interest also extends to nanoparticle drug delivery and immune memory formation. Dr. Maskey’s ultimate goal is to facilitate the development of safer, non-steroidal treatment options that are effective, personalized, and rooted in natural product pharmacology. His work contributes meaningfully to both the scientific community and clinical practice, offering promising alternatives for managing and preventing allergic and inflammatory disorders.

Awards and Honors

Dr. Anish R. Maskey has been the recipient of numerous prestigious awards and honors recognizing his academic excellence, innovative research, and impactful scientific contributions. He has won multiple travel scholarships from the American Academy of Allergy, Asthma & Immunology (AAAAI) from 2022 to 2025, allowing him to present his research at major national conferences. In 2023, he received the APFED travel grant and earned the Outstanding Abstract Award at Touro Research Day in 2024. He also secured second place for oral abstract presentation at the 1st PMI Conference at New York Medical College and was a runner-up in the ASBMB’s “Science in a Flash” competition. His publications have gained recognition as Top Cited and Top Downloaded articles by WILEY and The FASEB Journal. Furthermore, Dr. Maskey has been appointed as an Editorial Board Member for the International Journal of Infectious Diseases and Therapy and The FASEB Journal’s Early Career Researcher Board. His service as a peer reviewer for journals under Cell Press, Frontiers, MDPI, and Dove Medical Press further underscores his credibility and scientific leadership. These accolades collectively affirm his rising influence in the fields of immunology and translational medicine.

Conclusion

Dr. Anish R. Maskey is an outstanding candidate for the Best Researcher Award, especially in the category of early-career/postdoctoral researchers. His contributions to the fields of immunology and infectious diseases are substantive, innovative, and multidisciplinary. His leadership in research, commitment to mentoring, and active scholarly engagement make him exceptionally deserving of recognition.

Publications Top Notes

  • Title: A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS
    First Author: Wang ZZ
    Year: 2021
    Citations: 68

  • Title: Cytochrome P450 3A4 suppression by epimedium and kaempferol leads to synergistic anti-inflammatory effect with corticosteroid
    First Author: Li K
    Year: 2023
    Citations: 12

  • Title: Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and berberine with immunometabolism regulation
    First Author: Yang N
    Year: 2023
    Citations: 11

  • Title: Induction of severe eosinophilic esophagitis and multi-organ inflammation by airborne allergens
    First Author: Maskey A
    Year: 2022
    Citations: 9

  • Title: Formononetin inhibits B cell-IgE production by regulating XBP-1
    First Author: Yang N
    Year: 2023
    Citations: 7

  • Title: Anti-IgE effect of arctigenin on food allergy with a distinct transcriptome profile
    First Author: Cao M
    Year: 2022
    Citations: 6

  • Title: Computational analysis of 7,4’-Dihydroxyflavone on eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 3

  • Title: Efficacy of Ganoderic Acid C1 on corticosteroid-resistant neutrophilic airway inflammation
    First Author: Wang ZZ
    Year: 2024
    Citations: 2

  • Title: Berberine inhibits inflammatory response by S. aureus in atopic eczema
    First Author: Maskey AR
    Year: 2024
    Citations: 2

  • Title: Potency and chemical consistency of FAHF-2 for food allergy treatment
    First Author: Maskey A
    Year: 2020
    Citations: 2

  • Title: The gut microbiome and cross-reactivity of food allergens
    First Author: Taico Oliva C
    Year: 2025
    Citations: 1

  • Title: Preclinical models of atopic dermatitis for therapeutic investigations
    First Author: Maskey AR
    Year: 2024
    Citations: 1

  • Title: Berberine’s potential in attenuating S. aureus-induced inflammation
    First Author: Kwan M
    Year: 2024
    Citations: 1

  • Title: 7,4 Dihydroxy Flavone for treatment of eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 1

  • Title: Biomarkers and neurobiomarkers in allergic contact dermatitis
    First Author: Sasaki A
    Year: 2025
    Citations: Not listed

  • Title: Roles of bitter and sweet taste receptors in food allergy
    First Author: Xian M
    Year: 2025
    Citations: Not listed